Andreas Wirger

683 total citations
11 papers, 573 citations indexed

About

Andreas Wirger is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Andreas Wirger has authored 11 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Immunology. Recurrent topics in Andreas Wirger's work include Cell death mechanisms and regulation (3 papers), Immunotherapy and Immune Responses (3 papers) and Cancer Mechanisms and Therapy (2 papers). Andreas Wirger is often cited by papers focused on Cell death mechanisms and regulation (3 papers), Immunotherapy and Immune Responses (3 papers) and Cancer Mechanisms and Therapy (2 papers). Andreas Wirger collaborates with scholars based in Germany and United States. Andreas Wirger's co-authors include H. Drexler, Bernhard Schieffer, U. N. Riede, S. Seitz, Juergen Holtz, Frank Perabo, Doris Schmidt, Stefan C. Mueller, Alexander von Ruecker and Stefan C. Müller and has published in prestigious journals such as Circulation, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Andreas Wirger

11 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Wirger Germany 9 312 202 102 92 72 11 573
G Prinò Italy 13 103 0.3× 138 0.7× 101 1.0× 47 0.5× 40 0.6× 51 557
Jingjing Jiang China 10 183 0.6× 140 0.7× 29 0.3× 67 0.7× 32 0.4× 21 447
Jin‐Ling Huo China 11 69 0.2× 210 1.0× 38 0.4× 141 1.5× 33 0.5× 19 486
Davide Caruso Italy 10 69 0.2× 303 1.5× 32 0.3× 206 2.2× 119 1.7× 24 561
Zhengrong Huang China 8 74 0.2× 187 0.9× 61 0.6× 133 1.4× 29 0.4× 11 427
Takayuki Kojima Japan 12 70 0.2× 133 0.7× 27 0.3× 65 0.7× 37 0.5× 29 389
Jin-Ho Kang South Korea 14 90 0.3× 258 1.3× 60 0.6× 113 1.2× 70 1.0× 26 629
Yoshimi Kakiuchi Japan 13 34 0.1× 183 0.9× 161 1.6× 86 0.9× 40 0.6× 23 630
Giuseppe Dell’Elba Italy 11 106 0.3× 102 0.5× 45 0.4× 29 0.3× 13 0.2× 18 483
Bengt Kull Sweden 8 81 0.3× 231 1.1× 41 0.4× 24 0.3× 14 0.2× 12 453

Countries citing papers authored by Andreas Wirger

Since Specialization
Citations

This map shows the geographic impact of Andreas Wirger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Wirger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Wirger more than expected).

Fields of papers citing papers by Andreas Wirger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Wirger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Wirger. The network helps show where Andreas Wirger may publish in the future.

Co-authorship network of co-authors of Andreas Wirger

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Wirger. A scholar is included among the top collaborators of Andreas Wirger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Wirger. Andreas Wirger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Perabo, Frank, et al.. (2006). Indirubin-3'-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer.. PubMed. 26(3A). 2129–35. 36 indexed citations
2.
Wirger, Andreas, Frank Perabo, Doris Schmidt, et al.. (2005). Flavopiridol, an inhibitor of cyclin-dependent kinases, induces growth inhibition and apoptosis in bladder cancer cells in vitro and in vivo.. PubMed. 25(6B). 4341–7. 32 indexed citations
3.
Perabo, Frank, Andreas Wirger, Doris Schmidt, et al.. (2005). Preclinical evaluation of superantigen (staphylococcal enterotoxin B) in the intravesical immunotherapy of superficial bladder cancer. International Journal of Cancer. 115(4). 591–598. 30 indexed citations
4.
Perabo, Frank, Andreas Wirger, Doris Schmidt, et al.. (2005). Carboxyamido-triazole (CAI) reverses the balance between proliferation and apoptosis in a rat bladder cancer model.. PubMed. 25(2A). 725–9. 6 indexed citations
5.
Perabo, Frank, et al.. (2005). Superantigen-activated mononuclear cells induce apoptosis in transitional cell carcinoma.. PubMed. 25(5). 3565–73. 22 indexed citations
6.
Perabo, Frank, Andreas Wirger, Heike Lindner, et al.. (2004). Carboxyamido-triazole (CAI), a signal transduction inhibitor induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2.. PubMed. 24(5A). 2869–77. 27 indexed citations
7.
Perabo, Frank, Doris Schmidt, Alexander von Rücker, et al.. (2003). 1005 Indirubin-3′-monoxime, a novel cdk-inhibitor induces cdk-1 and survivin dependent growth arrest and apoptosis in bladder cancer cells. European Journal of Cancer Supplements. 1(5). S301–S301. 1 indexed citations
8.
Perabo, Frank, Doris Schmidt, Heike Lindner, et al.. (2001). Bladder cancer cells acquire competent mechanisms to escape Fas-mediated apoptosis and immune surveillance in the course of malignant transformation. British Journal of Cancer. 84(10). 1330–1338. 29 indexed citations
9.
Perabo, Frank, Roland Mattes, Andreas Wirger, et al.. (2001). Soluble Fas and Fas-ligand in bladder cancer in vitro and in vivo. Urologic Oncology Seminars and Original Investigations. 6(4). 163–169. 20 indexed citations
10.
Perabo, Frank, Sunil Sharma, Andreas Wirger, et al.. (2001). Circulating intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin in urological malignancies.. PubMed. 38(1). 1–7. 18 indexed citations
11.
Schieffer, Bernhard, Andreas Wirger, S. Seitz, et al.. (1994). Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.. Circulation. 89(5). 2273–2282. 352 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Prinò Breakdown of academic impact, for papers by Jingjing Jiang Breakdown of academic impact, for papers by Jin‐Ling Huo Breakdown of academic impact, for papers by Davide Caruso Breakdown of academic impact, for papers by Zhengrong Huang Breakdown of academic impact, for papers by Takayuki Kojima Breakdown of academic impact, for papers by Jin-Ho Kang Breakdown of academic impact, for papers by Yoshimi Kakiuchi Breakdown of academic impact, for papers by Giuseppe Dell’Elba Breakdown of academic impact, for papers by Bengt Kull
Rankless by CCL
2026